Directory

>

Christopher James

avatar

Christopher James

Vice President, Investor Relations | Collegium Pharmaceutical, Inc.

New York, New York, United States

View contact details (it's free)

Christopher James

Summary

Christopher James is a seasoned professional in the pharmaceutical industry, currently serving as Vice President of Investor Relations at Collegium Pharmaceutical. With a robust educational background, including an M.D. from Yale University School of Medicine and a Bachelor's in Biological Science from Cornell University, he combines medical expertise with financial acumen. Christopher has a proven track record in managing investor relations and corporate communications across several biopharmaceutical companies, demonstrating his ability to enhance investor confidence and engagement. His dynamic leadership style fosters collaboration among cross-functional teams, and he is known for his strategic foresight in crisis management. Christopher's extensive experience spans various roles, from managing directors to senior vice president positions, showcasing his adaptability and commitment to driving growth in the life sciences sector. He is passionate about bridging the gap between scientific innovation and investor interests, ensuring the success of the organizations he represents.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Leadership Development

Innovation

Organisational experience

Corporate Experience

Christopher James

Work Experience

company logo

Vice President, Investor Relations at

Collegium Pharmaceutical, Inc.

January 2023 - Present

company logo

Vice President of Investor Relations & Corporate Communications at

MacroGenics, Inc.

June 2021 - August 2022

company logo

Director, Investor Relations at

Corcept Therapeutics

November 2017 - April 2021

company logo

Managing Director, Senior Biotechnology Analyst at

Ladenburg Thalmann & Co. Inc.

December 2016 - October 2017

company logo

Senior Vice President, Senior Equity Research Analyst at

FBR

February 2015 - November 2016

company logo

Managing Director, Senior Equity Research Analyst at

Brinson Patrick

July 2013 - February 2015

company logo

Senior Vice President Medical Affairs at

Retrophin, LLC

February 2012 - January 2013

company logo

Managing Director, Senior Equity Analyst at

MLV & Co

October 2009 - February 2012

company logo

Vice President, Senior Biotechnology Analyst at

Rodman & Renshaw

January 2006 - January 2009

company logo

Manager of New Product Planning at

Daiichi Sankyo US

January 2005 - January 2006

💼

Biotechnology Consultant at

Defined Health

January 2004 - January 2005

company logo

Neurosurgery Resident at

Memorial Sloan Kettering Cancer Center

June 2001 - May 2004

company logo

Neurosurgery Resident at

NewYork-Presbyterian Hospital

January 2001 - January 2004

Logos provided by Logo.dev

Christopher James

Education

Yale University School of Medicine, M.D.

January 1997 - January 2001

Cornell University, Bachelor Of Science

January 1995 - January 1997

United States Air Force Academy

January 1992 - January 1994

Frequently Asked Questions about Christopher James

What is Christopher James email address?

Christopher James's primary email address is ******@corcept.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Christopher James work for?

Christopher James is a Vice President, Investor Relations at Collegium Pharmaceutical, Inc., a company specializing in Pharmaceutical & Medicine Manufacturing.

Where Christopher James graduated from?

Christopher James holds a degree in Medicine from Yale University School of Medicine.

How can I directly contact Christopher James?

To contact Christopher James directly, you can use the email address ******@corcept.com. Complete contact information is available upon registration with Muraena.

Who is Christopher James?

Christopher James is a seasoned professional in the pharmaceutical industry, currently serving as Vice President of Investor Relations at Collegium Pharmaceutical. With a robust educational background, including an M.D. from Yale University School of Medicine and a Bachelor's in Biological Science from Cornell University, he combines medical expertise with financial acumen. Christopher has a proven track record in managing investor relations and corporate communications across several biopharmaceutical companies, demonstrating his ability to enhance investor confidence and engagement. His dynamic leadership style fosters collaboration among cross-functional teams, and he is known for his strategic foresight in crisis management. Christopher's extensive experience spans various roles, from managing directors to senior vice president positions, showcasing his adaptability and commitment to driving growth in the life sciences sector. He is passionate about bridging the gap between scientific innovation and investor interests, ensuring the success of the organizations he represents.

Christopher`s contact details

mail

******@corcept.com

**********@aya.yale.edu

******@collegiumpharma.com

******@macrogenics.com

Colleagues

avatar
Sean Spears

Vice President Marketing

avatar
Shirley Kuhlmann

EVP, Chief Administrative Officer & GC

avatar
Bart Dunn

Executive Vice President, Strategy & Corporate Development

avatar
Ron Weiss

Vice President, Commercial Operations

avatar
Michael Heffernan

Chairman, CEO

avatar
Kristi Paquette

VP, Market Access & Trade

Scott Dreyer

Executive Vice President and Chief Commerical Officer

avatar
Kelly Clements

Chief People Officer

avatar
Colleen Tupper

EVP & Chief Financial Officer

Heow Tan

VP, Technical Operations

View Contact details (it's free)
Request Profile Removal